Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen A Fletcher

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
The Lancet. Respiratory Medicine|February 21, 2017
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort studyJason R Andrews, Elisa Nemes, Michele Tameris, et al.
Plos One|February 26, 2013
The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan childrenGeorge M Warimwe, Linda M Murungi, Gathoni Kamuyu, et al.
Plos Neglected Tropical Diseases|October 27, 2015
T-Cell Responses Are Associated with Survival in Acute Melioidosis PatientsKemajittra Jenjaroen, Suchintana Chumseng, Manutsanun Sumonwiriya, et al.
BMC Infectious Diseases|June 11, 2014
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell responseMagali Matsumiya, Stephanie A Harris, Iman Satti, et al.
Plos One|September 15, 2015
Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis VaccinesSteven G Smith, Kaatje Smits, Simone A Joosten, et al.
Nature Communications|November 4, 2022
Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infantsIman Satti, Rachel E Wittenberg, Shuailin Li, et al.
Emerging Infectious Diseases|February 25, 2020
Human Immune Responses to Melioidosis and Cross-Reactivity to Low-Virulence Burkholderia Species, Thailand<sup>1</sup>Patpong Rongkard, Barbara Kronsteiner, Viriya Hantrakun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1Tamara K Berthoud, Matthew Hamill, Patrick J Lillie, et al.
BMC Infectious Diseases|December 4, 2014
Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85ARachel Tanner, Kristina Kakalacheva, Ellen Miller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and VaccinesMarco Schito, Giovanni Battista Migliori, Helen A Fletcher, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
The Lancet. Respiratory Medicine|February 21, 2017
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort studyJason R Andrews, Elisa Nemes, Michele Tameris, et al.
Plos One|February 26, 2013
The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan childrenGeorge M Warimwe, Linda M Murungi, Gathoni Kamuyu, et al.
Plos Neglected Tropical Diseases|October 27, 2015
T-Cell Responses Are Associated with Survival in Acute Melioidosis PatientsKemajittra Jenjaroen, Suchintana Chumseng, Manutsanun Sumonwiriya, et al.
BMC Infectious Diseases|June 11, 2014
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell responseMagali Matsumiya, Stephanie A Harris, Iman Satti, et al.
Plos One|September 15, 2015
Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis VaccinesSteven G Smith, Kaatje Smits, Simone A Joosten, et al.
Nature Communications|November 4, 2022
Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infantsIman Satti, Rachel E Wittenberg, Shuailin Li, et al.
Emerging Infectious Diseases|February 25, 2020
Human Immune Responses to Melioidosis and Cross-Reactivity to Low-Virulence Burkholderia Species, Thailand<sup>1</sup>Patpong Rongkard, Barbara Kronsteiner, Viriya Hantrakun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1Tamara K Berthoud, Matthew Hamill, Patrick J Lillie, et al.
BMC Infectious Diseases|December 4, 2014
Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85ARachel Tanner, Kristina Kakalacheva, Ellen Miller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and VaccinesMarco Schito, Giovanni Battista Migliori, Helen A Fletcher, et al.
Pageof 9